Christine MacDonald1, Colleen Norris2, Gwen Y Alton1, Simon Urschel1,3, Ari R Joffe1,3, Catherine J Morgan4,5,6. 1. Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. 2. Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada. 3. Women and Children's Health Research Institute, Edmonton, Alberta, Canada. 4. Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. cmorgan@ualberta.ca. 5. Women and Children's Health Research Institute, Edmonton, Alberta, Canada. cmorgan@ualberta.ca. 6. , Room 4-557 Edmonton Clinic Health Academy, 11405-87 Avenue, Edmonton, Alberta, Canada, T6G 1C9. cmorgan@ualberta.ca.
Abstract
BACKGROUND: Critical illness following heart transplantation can include acute kidney injury (AKI). Study objectives were to define the epidemiology of, risk factors for, or impact on outcomes of AKI after pediatric heart transplant. METHODS: Using data from a prospective study of 66 young children, we evaluated: (1) post-operative AKI rate (by pediatric modified RIFLE criteria); (2) pre, intra, and early post-operative AKI risk factors using stepwise logistic regression (3) effect of AKI on short-term outcomes (ventilation and length of pediatric intensive care unit (PICU) stay) using stepwise multiple regression. RESULTS: AKI occurred in 73 % of children. Pre-transplant ventilation and higher baseline estimated creatinine clearance (eCCl) were independent risk factors for AKI. Pre-operative inotrope use was associated with reduced risk of AKI. Tacrolimus level emerged as important in multivariable risk prediction. Children with AKI had a longer duration of ventilation and length of pediatric intensive care unit (PICU) stay, with AKI being an independent predictor. CONCLUSIONS: AKI was common after heart transplant and associated with more complicated early post-transplant course. Lower baseline eCCl was associated with lower incidence of AKI; this merits further investigation. The association of pre-operative inotropes with less AKI may reflect a pathophysiological mechanism or be a surrogate for clinical factors and management prior to transplant. Avoiding high tacrolimus levels may be a modifiable risk factor for AKI.
BACKGROUND:Critical illness following heart transplantation can include acute kidney injury (AKI). Study objectives were to define the epidemiology of, risk factors for, or impact on outcomes of AKI after pediatric heart transplant. METHODS: Using data from a prospective study of 66 young children, we evaluated: (1) post-operative AKI rate (by pediatric modified RIFLE criteria); (2) pre, intra, and early post-operative AKI risk factors using stepwise logistic regression (3) effect of AKI on short-term outcomes (ventilation and length of pediatric intensive care unit (PICU) stay) using stepwise multiple regression. RESULTS: AKI occurred in 73 % of children. Pre-transplant ventilation and higher baseline estimated creatinine clearance (eCCl) were independent risk factors for AKI. Pre-operative inotrope use was associated with reduced risk of AKI. Tacrolimus level emerged as important in multivariable risk prediction. Children with AKI had a longer duration of ventilation and length of pediatric intensive care unit (PICU) stay, with AKI being an independent predictor. CONCLUSIONS: AKI was common after heart transplant and associated with more complicated early post-transplant course. Lower baseline eCCl was associated with lower incidence of AKI; this merits further investigation. The association of pre-operative inotropes with less AKI may reflect a pathophysiological mechanism or be a surrogate for clinical factors and management prior to transplant. Avoiding high tacrolimus levels may be a modifiable risk factor for AKI.
Authors: Chirag R Parikh; Prasad Devarajan; Michael Zappitelli; Kyaw Sint; Heather Thiessen-Philbrook; Simon Li; Richard W Kim; Jay L Koyner; Steven G Coca; Charles L Edelstein; Michael G Shlipak; Amit X Garg; Catherine D Krawczeski Journal: J Am Soc Nephrol Date: 2011-08-11 Impact factor: 10.121
Authors: Scott I Aydin; Howard S Seiden; Andrew D Blaufox; Vincent A Parnell; Tarif Choudhury; Ann Punnoose; James Schneider Journal: Ann Thorac Surg Date: 2012-08-09 Impact factor: 4.330
Authors: Douglas Mah; Tajinder P Singh; Ravi R Thiagarajan; Kimberlee Gauvreau; Gary E Piercey; Elizabeth D Blume; Francis Fynn-Thompson; Christopher S D Almond Journal: J Heart Lung Transplant Date: 2009-09-26 Impact factor: 10.247
Authors: Michael Zappitelli; Pierre-Luc Bernier; Richard S Saczkowski; Christo I Tchervenkov; Ronald Gottesman; Adrian Dancea; Ayaz Hyder; Omar Alkandari Journal: Kidney Int Date: 2009-07-29 Impact factor: 10.612
Authors: K R Pedersen; J V Povlsen; S Christensen; J Pedersen; K Hjortholm; S H Larsen; V E Hjortdal Journal: Acta Anaesthesiol Scand Date: 2007-11 Impact factor: 2.105
Authors: Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: Amanda M Uber; Maria E Montez-Rath; David M Kwiatkowski; Catherine D Krawczeski; Scott M Sutherland Journal: Pediatr Nephrol Date: 2018-07-09 Impact factor: 3.714
Authors: Maaike A Sikma; Claudine C Hunault; Johannes H Kirkels; Marianne C Verhaar; Jozef Kesecioglu; Dylan W de Lange Journal: Eur J Drug Metab Pharmacokinet Date: 2018-06 Impact factor: 2.441